ZL0590

CAS No. 2230496-99-6

ZL0590( —— )

Catalog No. M28525 CAS No. 2230496-99-6

ZL0590 is an effective and selective inhibitor of BD1-BRD4 (IC50 = 90 nM) with anti-inflammatory activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 177 In Stock
5MG 155 In Stock
10MG 235 In Stock
25MG 424 In Stock
50MG 621 In Stock
100MG 916 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ZL0590
  • Note
    Research use only, not for human use.
  • Brief Description
    ZL0590 is an effective and selective inhibitor of BD1-BRD4 (IC50 = 90 nM) with anti-inflammatory activities.
  • Description
    ZL0590 is an effective and selective inhibitor of BD1-BRD4 (IC50 = 90 nM) with anti-inflammatory activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2230496-99-6
  • Formula Weight
    512.55
  • Molecular Formula
    C23H27F3N4O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (195.10 mM)
  • SMILES
    S(=O)(=O)(N1[C@H](CN2CCOCC2)CCC1)C3=CC=C(NC(NC4=CC=C(C(F)(F)F)C=C4)=O)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Oxypeucedanin hydrat...

    Oxypeucedanin hydrate exhibits carbohydrate metabolizing enzymes inhibitory effect.

  • FHD-286

    FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.

  • RVX-208

    RVX-208 is a potent BET bromodomain inhibitor with IC50 of 0.510 μM for BD2 in a cell-free assay, about 170-fold selectivity over BD1. Phase 2.